Biotechnology, the science of using living cells to create medicines, has become a leading source of therapies for patients. Since the mid-1980s, several breakthrough discoveries in biology, life sciences, and medicine laid the foundation for this revolutionary class of medicines.
Mankind Pharma, with its focus on developing affordable medicines, embarked on a journey to create high-quality biosimilars. These biosimilars are designed to reliably serve both doctors and patients. Our primary focus areas are:
Chronic Inflammatory Diseases
Oncology
Metabolic and Lifestyle Disorders
lass="text-gray-600 mb-6 font-regular"> To achieve the goal of producing affordable, high- quality biosimilars, Mankind Pharma has invested in advanced R&D infrastructure. Dedicated teams of experienced scientists work on the development and delivery of these medicines.
